MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cellular senescence induced by paraquat drives neuropathology associated with Parkinson’s disease

S.J. Chinta, G. Woods, M. Demaria, J. Campisi, J.K. Andersen (Novato, CA, USA)

Meeting: 2016 International Congress

Abstract Number: 776

Keywords: Aging, Cell death, Dopaminergic neurons, Paraquat

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To understand the role of cellular senescence in brain aging and neurodegeneration in Parkinson’s disease models.

Background: Although cellular senescence has been causally linked to age-related pathologies outside the brain, little is known about its role in the brain aging, much less in age-related neurodegenerative diseases. Of recent interest, however, expression of the tumor suppressor and senescence marker p16INK4a and the SASP factor matrix metalloproteinase (MMP) 3 increased significantly in the brain during normal aging, and were even higher in affected cortical brain tissues from patients with Alzheimer’s disease. Here, we examined postmortem human brain tissue and found that the incidence of PD correlated with expression of senescence markers, suggesting that senescent cells may contribute to PD. To test this hypothesis, we examined cell culture and mouse models of PD for the presence of senescent cells. Importantly, using a mouse model in which senescent cells can be inducibly ablated, we studied the role of senescent cells in PD-associated phenotypes associated with systemic PQ exposure.

Methods: We used both cell culture and mouse models of PD to examine the role of cellular senescence in aging and neurodegeneration associated with PD.

Results: We show that pesticide PQ induces senescence in astrocytes, the most abundant proliferation-competent cells in the brain, in culture and in vivo. Importantly, using a genetic mouse model to eliminate senescent cells, we show that senescent cell ablation protects against PD-like neuropathologies after systemic PQ administration. Senescent cell markers increased following PQ administration, and were present in astrocytes in affected PD patient midbrain tissues.

Conclusions: Thus, cellular senescence can be induced following exposure to an environmental agent linked to PD, and removal of senescent cells can be neuroprotective. Therapies targeted at preventing cellular senescence or eliminating senescent cells may therefore constitute a novel therapeutic strategy for PD.

To cite this abstract in AMA style:

S.J. Chinta, G. Woods, M. Demaria, J. Campisi, J.K. Andersen. Cellular senescence induced by paraquat drives neuropathology associated with Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/cellular-senescence-induced-by-paraquat-drives-neuropathology-associated-with-parkinsons-disease/. Accessed May 10, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cellular-senescence-induced-by-paraquat-drives-neuropathology-associated-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley